• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 12220
Device Problems Unexpected Therapeutic Results (1631); Infusion or Flow Problem (2964); No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/24/2022
Event Type  malfunction  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported the alarm cells were detected in plasma line from centrifuge.The plasma in the connector is discolored cherry color during a red blood cell exchange (rbcx) procedure on a sickle cell patient.Terumo bct customer support asked the operator to pause the machine and call the locations dr.The dr.Ordered a transfusion panel reaction test, the lab did not see any hemolysis from the pre cbc.Per follow up from the customer, the dr.Cancelled the transfusion reaction panel and the dr.Sent the patient home, the patient will come back next month for a rbcx procedure.The customer stated that the dr.Was not worried about the hemolysis levels in the disposable set.Per the customer the patient is stable the collection set is not available for return because it was discarded by the customer.Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in h6 and h10.Investigation: further evaluation of this event has determined that the device did not cause or contribute to a death or serious injury, nor is there a likely potential for death or serious injury associated with this event based on additional investigational information.Per the customer, they experience some hemolysis every time the patient comes for the rbcx treatment and they believe it is due to poor access from the vortex port and progression of disease.Hemolysis was observed in the connector two hours into the procedure.The device alarmed ¿cells were detected in plasma line from centrifuge¿.A doctor ordered a transfusion reaction panel.The customer informed clinical support that the doctor cancelled the transfusion reaction panel and sent the patient home.The doctor was not worried about the hemolysis levels in the set.The customer reported that they had a lot of problems with the vortex port previously and was told by the rest of the nurses that deal with the same patient every four weeks that they experience some hemolysis every time the patient comes in for rbx treatment.The nurses believe the hemolysis is due to poor access from the vortex port and progression of the disease.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.No further reporting will be provided as this does not represent a reportable event.
 
Event Description
The customer would like the following run data file investigated to determine a possible cause for the higher-than-expected wbc content in the platelet product.Donor unit #: (b)(6) there was not a transfusion recipient or patient involved at the time of the residual wbc testing, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key13841225
MDR Text Key297869245
Report Number1722028-2022-00090
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583122208
UDI-Public35020583122209
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 03/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/01/2024
Device Model Number12220
Device Catalogue Number12220
Device Lot Number2202023130
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/24/2022
Initial Date FDA Received03/21/2022
Supplement Dates Manufacturer Received11/30/2022
Supplement Dates FDA Received12/09/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
Patient Weight107 KG
-
-